{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T11:26:29Z","timestamp":1794137189973,"version":"4.8.0"},"reference-count":484,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T00:00:00Z","timestamp":1782259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.apsb.2026.06.047","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T23:42:06Z","timestamp":1782517326000},"page":"4770-4807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Inflammation in atherosclerosis: Drivers, mechanisms and therapies"],"prefix":"10.1016","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-2933-5522","authenticated-orcid":false,"given":"Zihan","family":"Su","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5488-5217","authenticated-orcid":false,"given":"Suowen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2026.06.047_bib1","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1753-4887.1989.tb02747.x","article-title":"Cellular pathology. As based upon physiological and pathological histology. Lecture XVI\u2014Atheromatous affection of arteries. 1858","volume":"47","author":"Virchow","year":"1989","journal-title":"Nutr Rev"},{"key":"10.1016\/j.apsb.2026.06.047_bib2","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM197608122950707","article-title":"The pathogenesis of atherosclerosis (first of two parts)","volume":"295","author":"Ross","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014An inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib4","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib6","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with Canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib7","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa2021372","article-title":"Colchicine in patients with chronic coronary disease","volume":"383","author":"Nidorf","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib8","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib9","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.1016\/S0140-6736(21)00520-1","article-title":"IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"397","author":"Ridker","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.06.047_bib10","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib11","first-page":"805","article-title":"Loss-of-function mutations in Dnmt3a and Tet2 lead to accelerated atherosclerosis and concordant macrophage phenotypes","volume":"2","author":"Rauch","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib12","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/s41586-021-03341-5","article-title":"The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis","volume":"592","author":"Fidler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib13","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.047_bib14","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal Hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2021.01.049","article-title":"Increased stem cell proliferation in atherosclerosis accelerates clonal hematopoiesis","volume":"184","author":"Heyde","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.047_bib16","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1038\/s41591-024-03213-1","article-title":"Unidirectional association of clonal hematopoiesis with atherosclerosis development","volume":"30","author":"Diez","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib17","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41586-024-07693-6","article-title":"Alternating high-fat diet enhances atherosclerosis by neutrophil reprogramming","volume":"634","author":"Lavillegrand","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41586-024-07993-x","article-title":"Early intermittent hyperlipidaemia alters tissue macrophages to fuel atherosclerosis","volume":"634","author":"Takaoka","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib19","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41586-025-08792-8","article-title":"Sensing ceramides by CYSLTR2 and P2RY6 to aggravate atherosclerosis","volume":"641","author":"Zhang","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib20","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1016\/j.cell.2022.04.004","article-title":"Atherosclerosis: recent developments","volume":"185","author":"Bjorkegren","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.047_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/cvr\/cvac066.185","article-title":"Endothelial CaSR is involved in the induction of atherosclerosis by promoting cell adhesion and local inflammation","volume":"118","author":"Sundararaman","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s44161-023-00224-y","article-title":"The angiopoietin receptor Tie2 is atheroprotective in arterial endothelium","volume":"2","author":"Anisimov","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib23","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCRESAHA.121.319582","article-title":"Endothelial cells induced progenitors into brown fat to reduce atherosclerosis","volume":"131","author":"Park","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib24","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/CIRCRESAHA.108.192286","article-title":"The orphan nuclear receptor Nur77 suppresses endothelial cell activation through induction of I\u03baB\u03b1 expression","volume":"104","author":"You","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib25","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1161\/CIRCRESAHA.122.321837","article-title":"NDRG1 signaling is essential for endothelial inflammation and vascular remodeling","volume":"132","author":"Zhang","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib26","doi-asserted-by":"crossref","first-page":"29847","DOI":"10.18632\/oncotarget.4913","article-title":"NDRG1 promotes growth of hepatocellular carcinoma cells by directly interacting with GSK-3\u03b2 and Nur77 to prevent \u03b2-catenin degradation","volume":"6","author":"Lu","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2026.06.047_bib27","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1093\/cvr\/cvac193","article-title":"Endothelial PTP4A1 mitigates vascular inflammation via USF1\/A20 axis-mediated NF-\u03baB inactivation","volume":"119","author":"Cho","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehad655.3290","article-title":"The endoplasmic reticulum (ER) chaperone GRP78 is secreted during ER stress and alleviates endothelial cell inflammation","volume":"44","author":"Repges","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102290","article-title":"Hsp90 S-nitrosylation at Cys521, as a conformational switch, modulates cycling of Hsp90\u2013AHA1\u2013CDC37 chaperone machine to aggravate atherosclerosis","volume":"52","author":"Zhao","year":"2022","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib30","article-title":"Endothelial AGO1 drives vascular inflammation and atherosclerosis via a non-canonical nuclear mechanism","author":"Liu","year":"2025","journal-title":"bioRxiv"},{"key":"10.1016\/j.apsb.2026.06.047_bib31","article-title":"Role of ADAR2-mediated innate immune responses in vascular inflammation and atherosclerosis","volume":"120","author":"Amponsah","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib32","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1161\/CIRCRESAHA.122.322360","article-title":"LncRNA PSMB8-AS1 instigates vascular inflammation to aggravate atherosclerosis","volume":"134","author":"Li","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3829","article-title":"MIR181A1HG is a novel long noncoding RNA regulating vascular inflammation and atherosclerosis","volume":"45","author":"Ni","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib34","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1093\/cvr\/cvae071","article-title":"Endothelial nucleotide-binding oligomerization domain-like receptor protein 3 inflammasome regulation in atherosclerosis","volume":"120","author":"Guo","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib35","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41418-025-01620-6","article-title":"HDAC3 activates endothelial NLRP3 inflammasome and promotes atherosclerosis via inhibiting the acetylation of specificity protein 1","volume":"33","author":"Chen","year":"2026","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2026.06.047_bib36","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1093\/cvr\/cvae257","article-title":"SGLT2 expression in human vasculature and heart correlates with low-grade inflammation and causes eNOS\u2013NO\/ROS imbalance","volume":"121","author":"Mroueh","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/JCI181928","article-title":"Endothelial MICU1 protects against vascular inflammation and atherosclerosis by inhibiting mitochondrial calcium uptake","volume":"135","author":"Sun","year":"2025","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib38","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1093\/cvr\/cvac036","article-title":"Endothelial OCT4 is atheroprotective by preventing metabolic and phenotypic dysfunction","volume":"118","author":"Shin","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib39","doi-asserted-by":"crossref","first-page":"A25","DOI":"10.1016\/j.jvs.2007.03.001","article-title":"Regulation of vascular smooth muscle cell differentiation","volume":"45","author":"Rzucidlo","year":"2007","journal-title":"J Vasc Surg"},{"key":"10.1016\/j.apsb.2026.06.047_bib40","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1080\/15548627.2022.2096397","article-title":"Chaperone-mediated autophagy protects against atherosclerosis","volume":"18","author":"Madrigal Matute","year":"2022","journal-title":"Autophagy"},{"key":"10.1016\/j.apsb.2026.06.047_bib41","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCRESAHA.120.318353","article-title":"SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis","volume":"128","author":"Grootaert","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib42","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/cvr\/cvae028","article-title":"Translatome profiling reveals Itih4 as a novel smooth muscle cell-specific gene in atherosclerosis","volume":"120","author":"Ravindran","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2026.111165","article-title":"ARF6 controls VSMC phenotypic switching upon lipid stimulation to promote inflammatory signaling contributing to the progression of atherosclerosis","volume":"302","author":"Fiola Masson","year":"2026","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.047_bib44","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1146\/annurev-physiol-012110-142315","article-title":"Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease","volume":"74","author":"Alexander","year":"2012","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib45","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.120.049922","article-title":"Fate and state of vascular smooth muscle cells in atherosclerosis","volume":"143","author":"Miano","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib46","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/cvr\/cvaf029","article-title":"Methyltransferase-like 3-catalysed N6-methyladenosine methylation facilitates the contribution of vascular smooth muscle cells to atherosclerosis","volume":"121","author":"Dong","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib47","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1093\/cvr\/cvaf036","article-title":"Novel role of vascular smooth muscle cell-expressed METTL3 in atherosclerosis","volume":"121","author":"Stuck","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib48","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae666.3867","article-title":"Smooth muscle cell-specific deletion of S100A4 modifies smooth muscle cell fate and inflammation in murine atherosclerotic lesions","volume":"45","author":"Azar","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib49","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1161\/CIRCRESAHA.122.321692","article-title":"FHL5 controls vascular disease-associated gene programs in smooth muscle cells","volume":"132","author":"Wong","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1161\/CIRCRESAHA.122.321538","article-title":"TXNIP suppresses the osteochondrogenic switch of vascular smooth muscle cells in atherosclerosis","volume":"132","author":"Woo","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib51","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCULATIONAHA.122.063402","article-title":"Multiomics of tissue extracellular vesicles identifies unique modulators of atherosclerosis and calcific aortic valve stenosis","volume":"148","author":"Blaser","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib52","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1164\/rccm.202203-0441OC","article-title":"Single-cell analysis reveals distinct immune and smooth muscle cell populations that contribute to chronic thromboembolic pulmonary hypertension","volume":"207","author":"Viswanathan","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib53","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/eurheartj\/ehae768","article-title":"Atheroma transcriptomics identifies ARNTL as a smooth muscle cell regulator and with clinical and genetic data improves risk stratification","volume":"46","author":"Narayanan","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib54","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s44161-022-00042-8","article-title":"Smad3 regulates smooth muscle cell fate and mediates adverse remodeling and calcification of the atherosclerotic plaque","volume":"1","author":"Cheng","year":"2022","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib55","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/cvr\/cvab056","article-title":"Cezanne is a critical regulator of pathological arterial remodelling by targeting \u03b2-catenin signalling","volume":"118","author":"An","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib56","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.7150\/thno.66456","article-title":"Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis","volume":"12","author":"Maiseyeu","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.06.047_bib57","doi-asserted-by":"crossref","first-page":"7500","DOI":"10.1038\/s41467-022-35330-1","article-title":"Extracellular traps from activated vascular smooth muscle cells drive the progression of atherosclerosis","volume":"13","author":"Zhai","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib58","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1161\/CIRCRESAHA.125.326366","article-title":"Long noncoding RNA MIR181A1HG takes a proinflammatory driver's seat in atherosclerosis by hijacking FOXP1","volume":"136","author":"Oo","year":"2025","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1161\/CIRCULATIONAHA.123.063760","article-title":"INKILN is a novel long noncoding RNA promoting vascular smooth muscle inflammation via scaffolding MKL1 and USP10","volume":"148","author":"Zhang","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib60","doi-asserted-by":"crossref","first-page":"4562","DOI":"10.1093\/eurheartj\/ehac097","article-title":"The epigenetic enzyme DOT1L orchestrates vascular smooth muscle cell\u2013monocyte crosstalk and protects against atherosclerosis via the NF-\u03baB pathway","volume":"43","author":"Farina","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib61","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/cvr\/cvad091","article-title":"Thrombin-activated interleukin-1\u03b1 drives atherogenesis, but also promotes vascular smooth muscle cell proliferation and collagen production","volume":"119","author":"Burzynski","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib62","doi-asserted-by":"crossref","DOI":"10.1172\/JCI165933","article-title":"DPP4 inhibition impairs senohemostasis to improve plaque stability in atherosclerotic mice","volume":"133","author":"Herman","year":"2023","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib63","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cvr\/cvab042","article-title":"The VWF\/LRP4\/\u03b1V\u03b23-axis represents a novel pathway regulating proliferation of human vascular smooth muscle cells","volume":"118","author":"Lagrange","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib64","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abe0357","article-title":"SVEP1 is a human coronary artery disease locus that promotes atherosclerosis","volume":"13","author":"Jung","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib65","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/cvr\/cvae131","article-title":"Macrophage-derived FGFR1 drives atherosclerosis through PLC\u03b3-mediated activation of NF-\u03baB inflammatory signalling pathway","volume":"120","author":"Wang","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib66","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/cvr\/cvab347","article-title":"Dynamic changes in chromatin accessibility are associated with the atherogenic transitioning of vascular smooth muscle cells","volume":"118","author":"Wang","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib67","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1093\/eurheartj\/ehae379","article-title":"TRAP1 drives smooth muscle cell senescence and promotes atherosclerosis via HDAC3-primed histone H4 lysine 12 lactylation","volume":"45","author":"Li","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib68","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.yjmcc.2021.12.012","article-title":"GALNT4 primes monocytes adhesion and transmigration by regulating O-glycosylation of PSGL-1 in atherosclerosis","volume":"165","author":"Ye","year":"2022","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib69","doi-asserted-by":"crossref","first-page":"4974","DOI":"10.1111\/bph.15926","article-title":"Gene-dosage effect of Pfkfb3 on monocyte\/macrophage biology in atherosclerosis","volume":"179","author":"Guo","year":"2022","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib70","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1161\/CIRCRESAHA.122.321146","article-title":"The FES gene at the 15q26 coronary-artery-disease locus inhibits atherosclerosis","volume":"131","author":"Karamanavi","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbamcr.2023.119479","article-title":"SVEP1 influences monocyte to macrophage differentiation via integrin \u03b14\u03b21\/\u03b19\u03b21 and Rho\/Rac signalling","volume":"1870","author":"Andrews","year":"2023","journal-title":"Biochim Biophys Acta Mol Cell Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.775447","article-title":"\u03b22 Integrin CD11d\/CD18: from expression to an emerging role in staged leukocyte migration","volume":"12","author":"Blythe","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib73","doi-asserted-by":"crossref","first-page":"25","DOI":"10.4049\/jimmunol.2200475","article-title":"Follicle-stimulating hormone provokes macrophages to secrete IL-1\u03b2 contributing to atherosclerosis progression","volume":"210","author":"Han","year":"2023","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib74","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.4049\/jimmunol.164.12.6166","article-title":"M-1\/M-2 macrophages and the Th1\/Th2 paradigm","volume":"164","author":"Mills","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib75","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41467-021-27862-9","article-title":"C-type lectin receptor CLEC4A2 promotes tissue adaptation of macrophages and protects against atherosclerosis","volume":"13","author":"Park","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib76","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1161\/CIRCRESAHA.109.215715","article-title":"Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2","volume":"107","author":"Kadl","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109100","article-title":"Collagen VI antibody reduces atherosclerosis by activating monocyte\/macrophage polarization in ApoE\u2013\/\u2013 mice","volume":"111","author":"Liu","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib78","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1161\/CIRCRESAHA.110.233775","article-title":"Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPAR\u03b3 and LXR\u03b1 pathways","volume":"108","author":"Chinetti","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib79","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s10565-022-09768-4","article-title":"TRIM64 promotes ox-LDL-induced foam cell formation, pyroptosis, and inflammation in THP-1-derived macrophages by activating a feedback loop with NF-\u03baB via I\u03baB\u03b1 ubiquitination","volume":"39","author":"Zhu","year":"2023","journal-title":"Cell Biol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.047_bib80","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1093\/cvr\/cvae183","article-title":"Olfr2+ macrophages: monocyte-derived, pro-inflammatory foamy-like cells in atherosclerosis","volume":"120","author":"Cochain","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib81","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1093\/cvr\/cvae153","article-title":"Olfr2-positive macrophages originate from monocytes proliferate in situ and present a pro-inflammatory foamy-like phenotype","volume":"120","author":"Armstrong Suthahar","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib82","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1126\/science.abg3067","article-title":"Olfactory receptor 2 in vascular macrophages drives atherosclerosis by NLRP3-dependent IL-1 production","volume":"375","author":"Orecchioni","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.047_bib83","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116639","article-title":"Interleukin-1\/Toll-like receptor signaling potentiates macrophage olfactory receptor 2-driven atherosclerosis","volume":"44","author":"Zhang","year":"2025","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib84","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1093\/cvr\/cvaf072","article-title":"Unravelling inflammation: the critical role of ETS2 in macrophage activation and chronic disease","volume":"121","author":"Ben-Aicha","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib85","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature19346","article-title":"The long non-coding RNA Morrbid regulates Bim and short-lived myeloid cell lifespan","volume":"537","author":"Kotzin","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib86","doi-asserted-by":"crossref","first-page":"187","DOI":"10.34133\/research.0187","article-title":"Leukocyte-specific morrbid promotes leukocyte differentiation and atherogenesis","volume":"6","author":"Xiang","year":"2023","journal-title":"Research"},{"key":"10.1016\/j.apsb.2026.06.047_bib87","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/bph.16367","article-title":"Monocytic microRNAs\u2014novel targets in atherosclerosis therapy","volume":"182","author":"Euler","year":"2025","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib88","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1161\/CIRCRESAHA.121.319120","article-title":"miR-223 exerts translational control of proatherogenic genes in macrophages","volume":"131","author":"Nguyen","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib89","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.3390\/ijms24065932","article-title":"IgG1 is the Optimal subtype for treating atherosclerosis by inducing M2 macrophage differentiation, and is independent of the Fc\u03b3RIIA gene polymorphism","volume":"24","author":"Duan","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib90","doi-asserted-by":"crossref","first-page":"681","DOI":"10.5551\/jat.65825","article-title":"The blockade of delta-like ligand 1 inhibits atherosclerotic lesion formation and attenuates plaque vulnerability","volume":"33","author":"Orkhonselenge","year":"2026","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/j.apsb.2026.06.047_bib91","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/s44161-023-00384-x","article-title":"Macrophage TREM2 as a new player in atherosclerosis","volume":"2","author":"Riksen","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib92","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s44161-024-00429-9","article-title":"TREM2 protects from atherosclerosis by limiting necrotic core formation","volume":"3","author":"Piollet","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib93","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/s44161-023-00354-3","article-title":"Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis","volume":"2","author":"Patterson","year":"2023","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib94","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1093\/eurheartj\/ehad796","article-title":"Macrophage P2Y6 receptor deletion attenuates atherosclerosis by limiting foam cell formation through phospholipase C\u03b2\/store-operated calcium entry\/calreticulin\/scavenger receptor A pathways","volume":"45","author":"Li","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib95","doi-asserted-by":"crossref","DOI":"10.1172\/JCI172578","article-title":"Increased LL37 in psoriasis and other inflammatory disorders promotes LDL uptake and atherosclerosis","volume":"134","author":"Nakamura","year":"2024","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib96","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154217","article-title":"Disruption of USP9X in macrophages promotes foam cell formation and atherosclerosis","volume":"132","author":"Wang","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib97","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1038\/s41467-025-57404-6","article-title":"E3 ubiquitin ligase RNF128 promotes Lys63-linked polyubiquitination on SRB1 in macrophages and aggravates atherosclerosis","volume":"16","author":"Liu","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib98","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/cvr\/cvac189","article-title":"Cholesterol accumulation in macrophages drives NETosis in atherosclerotic plaques via IL-1\u03b2 secretion","volume":"119","author":"Yalcinkaya","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib99","doi-asserted-by":"crossref","first-page":"4933","DOI":"10.1093\/eurheartj\/ehaf241","article-title":"Nuclear receptor Dax1 promotes atherosclerosis by lipid transport inhibition and autophagy suppression in macrophages","volume":"46","author":"Li","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib100","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1038\/s41467-023-36614-w","article-title":"GSDME-mediated pyroptosis promotes the progression and associated inflammation of atherosclerosis","volume":"14","author":"Wei","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib101","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1161\/CIRCULATIONAHA.124.069574","article-title":"METTL4-mediated mitochondrial DNA N6-methyldeoxyadenosine promoting macrophage inflammation and atherosclerosis","volume":"151","author":"Zheng","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib102","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1161\/CIRCRESAHA.123.323223","article-title":"CD147 sparks atherosclerosis by driving M1 phenotype and impairing efferocytosis","volume":"134","author":"Lv","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib103","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1093\/eurheartj\/ehab920","article-title":"Interferon regulatory factor-5-dependent CD11c+ macrophages contribute to the formation of rupture-prone atherosclerotic plaques","volume":"43","author":"Edsfeldt","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib104","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/s41467-024-44868-1","article-title":"Resolvin T4 enhances macrophage cholesterol efflux to reduce vascular disease","volume":"15","author":"Walker","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib105","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1126\/science.1092385","article-title":"Neutrophil extracellular traps kill bacteria","volume":"303","author":"Brinkmann","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.047_bib106","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.06.047_bib107","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1093\/eurheartj\/ehad711","article-title":"Beyond association: high neutrophil counts are a causal risk factor for atherosclerotic cardiovascular disease","volume":"44","author":"Soehnlein","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib108","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1093\/cvr\/cvae046","article-title":"Interleukin-1 receptor accessory protein blockade limits the development of atherosclerosis and reduces plaque inflammation","volume":"120","author":"Mulholland","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib109","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.3390\/antiox11122343","article-title":"Interleukin-33 induces neutrophil extracellular trap (NET) formation and macrophage necroptosis via enhancing oxidative stress and secretion of proatherogenic factors in advanced atherosclerosis","volume":"11","author":"Tembhre","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.apsb.2026.06.047_bib110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.apsb.2026.06.047_bib111","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1161\/CIRCRESAHA.120.315931","article-title":"Neutrophil extracellular traps participate in cardiovascular diseases: recent experimental and clinical insights","volume":"126","author":"Doring","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib112","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1394137","article-title":"S100a8\/A9 proteins: critical regulators of inflammation in cardiovascular diseases","volume":"11","author":"Sun","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib113","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/CIRCRESAHA.122.322418","article-title":"Destabilization of atherosclerotic plaque by bilirubin deficiency","volume":"132","author":"Chen","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib114","doi-asserted-by":"crossref","first-page":"9635","DOI":"10.1038\/s41467-025-64633-2","article-title":"Neutrophil elastase-activatable ratiometric photoacoustic nanoprobes for imaging atherosclerotic plaque vulnerability","volume":"16","author":"Cao","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib115","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/ATVBAHA.113.302919","article-title":"Platelets mediate oxidized low-density lipoprotein-induced monocyte extravasation and foam cell formation","volume":"34","author":"Badrnya","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib116","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2017.09.013","article-title":"Platelet-derived chemokines in inflammation and atherosclerosis","volume":"122","author":"Bakogiannis","year":"2019","journal-title":"Cytokine"},{"key":"10.1016\/j.apsb.2026.06.047_bib117","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1182\/blood-2012-09-454710","article-title":"Platelet factor 4 mediates vascular smooth muscle cell injury responses","volume":"121","author":"Shi","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.apsb.2026.06.047_bib118","doi-asserted-by":"crossref","first-page":"580","DOI":"10.3390\/ijms23020580","article-title":"Differential effects of platelet factor 4 (CXCL4) and its non-allelic variant (CXCL4L1) on cultured human vascular smooth muscle cells","volume":"23","author":"Kaczor","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2024.156581","article-title":"Platelet-derived sTLT-1 is associated with platelet-mediated inflammation in coronary artery disease patients","volume":"178","author":"Ali","year":"2024","journal-title":"Cytokine"},{"key":"10.1016\/j.apsb.2026.06.047_bib120","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114152","article-title":"IRGM\/Irgm1 deficiency inhibits neutrophil-platelet interactions and thrombosis in experimental atherosclerosis and arterial injury","volume":"158","author":"Sun","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.06.047_bib121","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s10557-021-07229-4","article-title":"The function and regulation of platelet P2Y12 receptor","volume":"37","author":"Li","year":"2023","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.apsb.2026.06.047_bib122","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1080\/10641963.2018.1510941","article-title":"Platelet microparticles-containing miR-4306 inhibits human monocyte-derived macrophages migration through VEGFA\/ERK1\/2\/NF-\u03baB signaling pathways","volume":"41","author":"Yang","year":"2019","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.apsb.2026.06.047_bib123","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1536\/ihj.23-365","article-title":"Platelet microparticle-derived miR-320b inhibits hypertension with atherosclerosis development by targeting ETFA","volume":"65","author":"He","year":"2024","journal-title":"Int Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib124","doi-asserted-by":"crossref","DOI":"10.1080\/20013078.2017.1322454","article-title":"Platelet extracellular vesicles induce a pro-inflammatory smooth muscle cell phenotype","volume":"6","author":"Vajen","year":"2017","journal-title":"J Extracell Vesicles"},{"key":"10.1016\/j.apsb.2026.06.047_bib125","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fimmu.2015.00048","article-title":"Breaking the mold: transcription factors in the anucleate platelet and platelet-derived microparticles","volume":"6","author":"Lannan","year":"2015","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib126","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1080\/09537104.2021.1902970","article-title":"Endothelial transmigration of platelets depends on soluble factors released by activated endothelial cells and monocytes","volume":"32","author":"Huilcaman","year":"2021","journal-title":"Platelets"},{"key":"10.1016\/j.apsb.2026.06.047_bib127","doi-asserted-by":"crossref","first-page":"9791","DOI":"10.7150\/thno.64601","article-title":"CLEC-2-dependent platelet subendothelial accumulation by flow disturbance contributes to atherogenesis in mice","volume":"11","author":"Tang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.06.047_bib128","doi-asserted-by":"crossref","first-page":"2672","DOI":"10.1093\/eurheartj\/ehad304","article-title":"Novel mechanisms and therapeutic targets in atherosclerosis: inflammation and beyond","volume":"44","author":"Weber","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib129","first-page":"5315","article-title":"Dendritic cell exosome\u2011shuttled miRNA146a regulates exosome\u2011induced endothelial cell inflammation by inhibiting IRAK\u20111: A feedback control mechanism","volume":"20","author":"Zhong","year":"2019","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib130","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1161\/CIRCRESAHA.109.210781","article-title":"Resident intimal dendritic cells accumulate lipid and contribute to the initiation of atherosclerosis","volume":"106","author":"Paulson","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib131","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1084\/jem.20082129","article-title":"Identification of antigen-presenting dendritic cells in mouse aorta and cardiac valves","volume":"206","author":"Choi","year":"2009","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib132","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1172\/JCI44925","article-title":"CCL17-expressing dendritic cells drive atherosclerosis by restraining regulatory T cell homeostasis in mice","volume":"121","author":"Weber","year":"2011","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib133","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.3390\/ijms25042450","article-title":"The evolving role of dendritic cells in atherosclerosis","volume":"25","author":"Britsch","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib134","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.ejphar.2017.08.016","article-title":"Antigen-presenting dendritic cells in atherosclerosis","volume":"816","author":"Gil Pulido","year":"2017","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/2054879","article-title":"Interleukin-27 ameliorates atherosclerosis in ApoE\u2013\/\u2013 mice through regulatory T cell augmentation and dendritic cell tolerance","volume":"2022","author":"Xu","year":"2022","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.apsb.2026.06.047_bib136","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.101830.4","article-title":"C\u2013C chemokine receptor 4 deficiency exacerbates early atherosclerosis in mice","volume":"13","author":"Tanaka","year":"2025","journal-title":"eLife"},{"key":"10.1016\/j.apsb.2026.06.047_bib137","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/S0002-9149(98)00033-2","article-title":"Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome","volume":"81","author":"Grundy","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib138","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib139","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.cell.2011.04.005","article-title":"Macrophages in the pathogenesis of atherosclerosis","volume":"145","author":"Moore","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.047_bib140","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/joim.13794","article-title":"Platelets as an inter-player between hyperlipidaemia and atherosclerosis","volume":"296","author":"Li","year":"2024","journal-title":"J Intern Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib141","doi-asserted-by":"crossref","first-page":"513","DOI":"10.3390\/md22110513","article-title":"2-Acetamidophenol (2-AAP) suppresses the progression of atherosclerosis by alleviating hyperlipidemia and attenuating the ferroptosis pathway","volume":"22","author":"Zang","year":"2024","journal-title":"Mar Drugs"},{"key":"10.1016\/j.apsb.2026.06.047_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116289","article-title":"DiDang decoction improves mitochondrial function and lipid metabolism via the HIF-1 signaling pathway to treat atherosclerosis and hyperlipidemia","volume":"308","author":"Wu","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib143","first-page":"331","article-title":"Ferroptosis: a potential target for the treatment of atherosclerosis","volume":"56","author":"Li","year":"2024","journal-title":"Acta Biochim Biophys Sin"},{"key":"10.1016\/j.apsb.2026.06.047_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1567994","article-title":"Ferroptosis in idiopathic pulmonary fibrosis: mechanisms, impact, and therapeutic opportunities","volume":"16","author":"Yao","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib145","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s11883-022-01071-1","article-title":"ANGPTL3 as a drug target in hyperlipidemia and atherosclerosis","volume":"24","author":"Mohamed","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib146","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/MOL.0000000000000040","article-title":"Updates on apolipoprotein CIII: fulfilling promise as a therapeutic target for hypertriglyceridemia and cardiovascular disease","volume":"25","author":"Zheng","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.apsb.2026.06.047_bib147","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.16","article-title":"The role of triglyceride-rich lipoproteins and their remnants in atherosclerotic cardiovascular disease","volume":"18","author":"Gabani","year":"2023","journal-title":"Eur Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib148","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1161\/ATVBAHA.124.321748","article-title":"ApoE Receptor-2 R952Q variant in macrophages elevates soluble LRP1 to potentiate hyperlipidemia and accelerate atherosclerosis in mice","volume":"45","author":"Turkson","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib149","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241813942","article-title":"Postprandial hyperlipidemia: its pathophysiology, diagnosis, atherogenesis, and treatments","volume":"24","author":"Yanai","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib150","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib151","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/ni.2639","article-title":"CD36 coordinates NLRP3 inflammasome activation by facilitating intracellular nucleation of soluble ligands into particulate ligands in sterile inflammation","volume":"14","author":"Sheedy","year":"2013","journal-title":"Nat Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib152","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11883-025-01323-w","article-title":"Cholesterol crystals as triggers of NLRP3 inflammasome activation in atherosclerosis","volume":"27","author":"Yalcinkaya","year":"2025","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib153","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abf2489","article-title":"Mitochondrial C5aR1 activity in macrophages controls IL-1\u03b2 production underlying sterile inflammation","volume":"6","author":"Niyonzima","year":"2021","journal-title":"Sci Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib154","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1038\/s41467-023-39586-z","article-title":"Macrophage-to-endothelial cell crosstalk by the cholesterol metabolite 27HC promotes atherosclerosis in male mice","volume":"14","author":"Yu","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib155","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1093\/cvr\/cvae195","article-title":"Liver-targeted Angptl4 silencing by antisense oligonucleotide treatment attenuates hyperlipidaemia and atherosclerosis development in APOE\u22173-Leiden.CETP mice","volume":"120","author":"Modder","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib156","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1161\/ATVBAHA.122.318137","article-title":"Trib1 deficiency promotes hyperlipidemia, inflammation, and atherosclerosis in LDL receptor knockout mice","volume":"43","author":"Arndt","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib157","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108876","article-title":"IL-38 in modulating hyperlipidemia and its related cardiovascular diseases","volume":"108","author":"Lai","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib158","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000048","article-title":"Overexpression of NgBR inhibits high-fat diet-induced atherosclerosis in ApoE-deficiency mice","volume":"7","author":"Gong","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib159","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22710","article-title":"Advanced glycation end products and their adverse effects: the role of autophagy","volume":"35","author":"Sruthi","year":"2021","journal-title":"J Biochem Mol Toxicol"},{"key":"10.1016\/j.apsb.2026.06.047_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115802","article-title":"Different types of cell death in diabetic endothelial dysfunction","volume":"168","author":"Shen","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.06.047_bib161","doi-asserted-by":"crossref","DOI":"10.1177\/03000605231164548","article-title":"Insulin resistance and cardiovascular disease","volume":"51","author":"Kosmas","year":"2023","journal-title":"J Int Med Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib162","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1093\/cvr\/cvq012","article-title":"Endothelial progenitor cells give rise to pro-angiogenic smooth muscle-like progeny","volume":"86","author":"Moonen","year":"2010","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib163","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jacc.2018.09.089","article-title":"Endothelial to mesenchymal transition in cardiovascular disease: JACC state-of-the-art review","volume":"73","author":"Kovacic","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib164","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.734550","article-title":"Endothelial to mesenchymal transition: an insight in atherosclerosis","volume":"8","author":"Huang","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib165","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2023.117313","article-title":"Lipid-lowering in diabetes: an update","volume":"394","author":"Chait","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.06.047_bib166","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-Rich Lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib167","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11883-022-00994-z","article-title":"Remnants, LDL, and the quantification of lipoprotein-associated risk in atherosclerotic cardiovascular disease","volume":"24","author":"Packard","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib168","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s11892-024-01555-1","article-title":"Impact of remnant cholesterol on cardiovascular risk in diabetes","volume":"24","author":"Elias-Lopez","year":"2024","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib169","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-023-06008-0","article-title":"Contribution of intestinal triglyceride-rich lipoproteins to residual atherosclerotic cardiovascular disease risk in individuals with type 2 diabetes on statin therapy","volume":"66","author":"Taskinen","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/j.apsb.2026.06.047_bib170","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117545","article-title":"Modification of lipoprotein metabolism and function driving atherogenesis in diabetes","volume":"394","author":"Luciani","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.06.047_bib171","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1111\/j.1472-8206.2009.00739.x","article-title":"Lipid modification in type 2 diabetes: the role of LDL and HDL","volume":"23","author":"Verges","year":"2009","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib172","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1093\/eurheartj\/ehz962","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"41","author":"Boren","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib173","doi-asserted-by":"crossref","first-page":"2879","DOI":"10.3390\/ijms23052879","article-title":"Hyperglycemia promotes endothelial cell senescence through AQR\/PLAU signaling axis","volume":"23","author":"Wan","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib174","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94097-5","article-title":"Cellular senescence promotes endothelial activation through epigenetic alteration, and consequently accelerates atherosclerosis","volume":"11","author":"Honda","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib175","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.654494","article-title":"The dual regulation of apoptosis by Flavivirus","volume":"12","author":"Pan","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib176","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.3390\/cancers13133210","article-title":"Epigenetic deregulation of apoptosis in cancers","volume":"13","author":"Ozyerli Goknar","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.apsb.2026.06.047_bib177","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1007\/s00018-018-2983-9","article-title":"Endothelial cell apoptosis and the role of endothelial cell-derived extracellular vesicles in the progression of atherosclerosis","volume":"76","author":"Paone","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib178","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.651021","article-title":"From metabolic syndrome to neurological diseases: role of autophagy","volume":"9","author":"Maiuolo","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib179","article-title":"Metformin reduces saturated fatty acid-induced lipid accumulation and inflammatory response by restoration of autophagic flux in endothelial cells","volume":"10","author":"Kim","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib180","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24586","article-title":"SIRT3 attenuates coronary atherosclerosis in diabetic patients by regulating endothelial cell function","volume":"36","author":"Gong","year":"2022","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.apsb.2026.06.047_bib181","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 international Society of Hypertension Global Hypertension Practice Guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.apsb.2026.06.047_bib182","doi-asserted-by":"crossref","first-page":"7910","DOI":"10.3390\/ijms24097910","article-title":"Atherosclerosis and inflammation: insights from the theory of general pathological processes","volume":"24","author":"Gusev","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib183","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbiomech.2024.112212","article-title":"Impact of hypertension and arterial wall expansion on transport properties and atherosclerosis progression","volume":"174","author":"Hernandez-Lopez","year":"2024","journal-title":"J Biomech"},{"key":"10.1016\/j.apsb.2026.06.047_bib184","article-title":"The effect of blood pressure variability on coronary atherosclerosis plaques","volume":"9","author":"Liu","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s10495-024-02029-1","article-title":"The contributory role of GSK3\u03b2 in hypertension exacerbating atherosclerosis by regulating the OMA1\/PGC1\u03b1 pathway","volume":"30","author":"Bao","year":"2025","journal-title":"Apoptosis"},{"key":"10.1016\/j.apsb.2026.06.047_bib186","doi-asserted-by":"crossref","first-page":"15009","DOI":"10.1523\/JNEUROSCI.0892-11.2011","article-title":"Blood-borne angiotensin II acts in the brain to influence behavioral and endocrine responses to psychogenic stress","volume":"31","author":"Krause","year":"2011","journal-title":"J Neurosci"},{"key":"10.1016\/j.apsb.2026.06.047_bib187","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1172\/JCI86950","article-title":"Perivascular macrophages mediate the neurovascular and cognitive dysfunction associated with hypertension","volume":"126","author":"Faraco","year":"2016","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib188","doi-asserted-by":"crossref","first-page":"4789","DOI":"10.1113\/JP284078","article-title":"Neuroimmune modulation for targeting organ damage in hypertension and atherosclerosis","volume":"602","author":"Perrotta","year":"2024","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib189","doi-asserted-by":"crossref","first-page":"6702","DOI":"10.3390\/ijms22136702","article-title":"Renin-angiotensin system in pathogenesis of atherosclerosis and treatment of CVD","volume":"22","author":"Poznyak","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib190","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/s41440-025-02261-5","article-title":"Oxidized LDL enhances Gq signaling and aldosterone production by angiotensin II via the AT1\u2013LOX-1 receptor complex in adrenal cells","volume":"48","author":"Ihara","year":"2025","journal-title":"Hypertens Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib191","article-title":"Angiotensin II induces endothelial dysfunction and vascular remodeling by downregulating TRPV4 channels","volume":"6","author":"Kondapalli","year":"2023","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib192","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.3390\/ijms21124525","article-title":"Angiotensin II, Hypercholesterolemia, and vascular smooth muscle cells: a perfect trio for vascular pathology","volume":"21","author":"St Paul","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib193","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/s41419-019-1590-5","article-title":"Angiotensin II inhibits apoptosis of mouse aortic smooth muscle cells through regulating the circNRG-1\/miR-193b-5p\/NRG-1 axis","volume":"10","author":"Sun","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.06.047_bib194","doi-asserted-by":"crossref","first-page":"7527","DOI":"10.3390\/ijms26157527","article-title":"Angiotensin II and atherosclerosis: a new cardiovascular risk factor beyond hypertension","volume":"26","author":"Morat","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib195","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3390\/cimb47070501","article-title":"Angiotensin II and cardiovascular disease: balancing pathogenic and protective pathways","volume":"47","author":"Bayraktutan","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib196","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241411295","article-title":"Endothelin-1 in health and disease","volume":"24","author":"Banecki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib197","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112443","article-title":"Endothelium-specific endothelin-1 expression promotes pro-inflammatory macrophage activation by regulating miR-33\/NR4A axis","volume":"399","author":"Zhang","year":"2021","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib198","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1093\/cvr\/cvaa168","article-title":"Endothelium-restricted endothelin-1 overexpression in type 1 diabetes worsens atherosclerosis and immune cell infiltration via NOX1","volume":"117","author":"Ouerd","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib199","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5114\/aoms.2019.86770","article-title":"The association of endothelin-1 gene polymorphism and its plasma levels with hypertension and coronary atherosclerosis","volume":"17","author":"Ebrahimi","year":"2019","journal-title":"Archives of medical science\u202f: AMS"},{"key":"10.1016\/j.apsb.2026.06.047_bib200","doi-asserted-by":"crossref","first-page":"8504","DOI":"10.1111\/jcmm.16812","article-title":"LncRNA-HOTAIR promotes endothelial cell pyroptosis by regulating the miR-22\/NLRP3 axis in hyperuricaemia","volume":"25","author":"Chi","year":"2021","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib201","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1186\/s12882-019-1506-8","article-title":"Uric acid regulates NLRP3\/IL-1\u03b2 signaling pathway and further induces vascular endothelial cells injury in early CKD through ROS activation and K+ efflux","volume":"20","author":"Yin","year":"2019","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.apsb.2026.06.047_bib202","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202300393R","article-title":"Hyperuricemia: a key contributor to endothelial dysfunction in cardiovascular diseases","volume":"37","author":"Wei","year":"2023","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.047_bib203","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2741\/3950","article-title":"Uric acid, hyperuricemia and vascular diseases","volume":"17","author":"Jin","year":"2012","journal-title":"Front Biosci (Landmark Ed)"},{"key":"10.1016\/j.apsb.2026.06.047_bib204","article-title":"The dysregulation of immune cells induced by uric acid: mechanisms of inflammation associated with hyperuricemia and its complications","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib205","doi-asserted-by":"crossref","first-page":"3843","DOI":"10.3390\/cells11233843","article-title":"The role of oxidative stress in atherosclerosis","volume":"11","author":"Batty","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.apsb.2026.06.047_bib206","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCRESAHA.116.309326","article-title":"Roles of vascular oxidative stress and nitric oxide in the pathogenesis of atherosclerosis","volume":"120","author":"Forstermann","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib207","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1089\/ars.2014.6221","article-title":"NOX4 NADPH oxidase-dependent mitochondrial oxidative stress in aging-associated cardiovascular disease","volume":"23","author":"Vendrov","year":"2015","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2026.06.047_bib208","doi-asserted-by":"crossref","first-page":"H3227","DOI":"10.1152\/ajpheart.00998.2007","article-title":"Dimethylarginine dimethylaminohydrolase (DDAH): expression, regulation, and function in the cardiovascular and renal systems","volume":"293","author":"Palm","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2021.102108","article-title":"Hyperuricemia induces endothelial dysfunction and accelerates atherosclerosis by disturbing the asymmetric dimethylarginine\/dimethylarginine dimethylaminotransferase 2 pathway","volume":"46","author":"Lee","year":"2021","journal-title":"Redox Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib210","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4391920","article-title":"Uric acid induces endothelial dysfunction by activating the HMGB1\/RAGE signaling pathway","volume":"2017","author":"Cai","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.apsb.2026.06.047_bib211","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCRESAHA.109.212217","article-title":"The RAGE axis: a fundamental mechanism signaling danger to the vulnerable vasculature","volume":"106","author":"Yan","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib212","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1111\/jcmm.14262","article-title":"A functional interaction between Hippo\u2013YAP signalling and SREBPs mediates hepatic steatosis in diabetic mice","volume":"23","author":"Shu","year":"2019","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib213","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/jcp.31038","article-title":"Hyperuricemia promotes the progression of atherosclerosis by activating endothelial cell pyroptosis via the ROS\/NLRP3 pathway","volume":"238","author":"He","year":"2023","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib214","doi-asserted-by":"crossref","first-page":"13334","DOI":"10.1096\/fj.201901148R","article-title":"Uric acid induced the phenotype transition of vascular endothelial cells via induction of oxidative stress and glycocalyx shedding","volume":"33","author":"Ko","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.047_bib215","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1080\/0886022X.2022.2036620","article-title":"Research progress on related mechanisms of uric acid activating NLRP3 inflammasome in chronic kidney disease","volume":"44","author":"Wang","year":"2022","journal-title":"Ren Fail"},{"key":"10.1016\/j.apsb.2026.06.047_bib216","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9304383","article-title":"High level of uric acid promotes atherosclerosis by targeting NRF2-mediated autophagy dysfunction and ferroptosis","volume":"2022","author":"Yu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.apsb.2026.06.047_bib217","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1089\/ars.2024.0672","article-title":"Ferroptosis mediates the progression of hyperuricemic nephropathy by activating RAGE signaling","volume":"43","author":"Wang","year":"2025","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2026.06.047_bib218","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijms23031308","article-title":"Involvement of fatty acids and their metabolites in the development of inflammation in atherosclerosis","volume":"23","author":"Kotlyarov","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib219","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1016\/j.jtcvs.2019.10.152","article-title":"Nucleophosmin contributes to vascular inflammation and endothelial dysfunction in atherosclerosis progression","volume":"161","author":"Rao","year":"2021","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.apsb.2026.06.047_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2025.100774","article-title":"Palmitic acid alters enhancers\/super-enhancers near inflammatory and efferocytosis-associated genes in human monocytes","volume":"66","author":"Tanwar","year":"2025","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib221","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1340247","article-title":"miR-133a-3p\/TRPM4 axis improves palmitic acid induced vascular endothelial injury","volume":"14","author":"Xue","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib222","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/ATVBAHA.122.318536","article-title":"Palmitic acid\u2013induced long noncoding RNA PARAIL regulates inflammation via interaction with RNA-binding protein ELAVL1 in monocytes and macrophages","volume":"43","author":"Tanwar","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib223","doi-asserted-by":"crossref","first-page":"8273","DOI":"10.1038\/s41467-024-52621-x","article-title":"Lipid droplets sequester palmitic acid to disrupt endothelial ciliation and exacerbate atherosclerosis in male mice","volume":"15","author":"Tan","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib224","doi-asserted-by":"crossref","DOI":"10.1016\/j.plipres.2024.101289","article-title":"Impact of dietary n-6\/n-3 fatty acid ratio of atherosclerosis risk: a review","volume":"95","author":"Cao","year":"2024","journal-title":"Prog Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib225","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-44030-9","article-title":"Replacement of saturated fatty acids with linoleic acid in western diet attenuates atherosclerosis in a mouse model with inducible ablation of hepatic LDL receptor","volume":"13","author":"Burr","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib226","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11883-022-01075-x","article-title":"Role of Omega-3 fatty acids in cardiovascular disease: the debate continues","volume":"25","author":"Sherratt","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib227","doi-asserted-by":"crossref","first-page":"467","DOI":"10.3390\/biomedicines9050467","article-title":"Anti-atherosclerotic potential of free fatty acid receptor 4 (FFAR4)","volume":"9","author":"Kiepura","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.06.047_bib228","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100106","article-title":"EPA and DHA containing phospholipids have contrasting effects on membrane structure","volume":"62","author":"Sherratt","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib229","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1271001","article-title":"Short-chain fatty acids are potential goalkeepers of atherosclerosis","volume":"14","author":"Feng","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib230","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/s13578-023-01038-y","article-title":"FFAR2 antagonizes TLR2- and TLR3-induced lung cancer progression via the inhibition of AMPK\u2013TAK1 signaling axis for the activation of NF-\u03baB","volume":"13","author":"Kim","year":"2023","journal-title":"Cell Biosci"},{"key":"10.1016\/j.apsb.2026.06.047_bib231","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s40168-018-0439-y","article-title":"Microbiome\u2013host systems interactions: protective effects of propionate upon the blood\u2013brain barrier","volume":"6","author":"Hoyles","year":"2018","journal-title":"Microbiome"},{"key":"10.1016\/j.apsb.2026.06.047_bib232","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101706","article-title":"Short-chain fatty acid metabolism and multiple effects on cardiovascular diseases","volume":"81","author":"Hu","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.apsb.2026.06.047_bib233","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.3390\/ijms24021171","article-title":"The beneficial effects of pine nuts and its major fatty acid, pinolenic acid, on inflammation and metabolic perturbations in inflammatory disorders","volume":"24","author":"Takala","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib234","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s42003-025-07656-1","article-title":"Targeting fatty acid synthase reduces aortic atherosclerosis and inflammation","volume":"8","author":"Meade","year":"2025","journal-title":"Commun Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib235","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.yjmcc.2024.05.010","article-title":"MiR-127-3p enhances macrophagic proliferation via disturbing fatty acid profiles and oxidative phosphorylation in atherosclerosis","volume":"193","author":"Liu","year":"2024","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib236","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00018-022-04286-2","article-title":"Adipokines, adiposity, and atherosclerosis","volume":"79","author":"Liu","year":"2022","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib237","first-page":"269","article-title":"Role of leptin in atherogenesis","volume":"11","author":"Dubey","year":"2006","journal-title":"Exp Clin Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib238","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.mce.2012.12.009","article-title":"Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells","volume":"366","author":"Hirai","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.047_bib239","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ijcard.2018.07.112","article-title":"Resistin exerts a beneficial role in atherosclerotic plaque inflammation by inhibiting neutrophil migration","volume":"272","author":"Liberale","year":"2018","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib240","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1530\/EJE-09-0380","article-title":"Chemerin is associated with markers of inflammation and components of the metabolic syndrome but does not predict coronary atherosclerosis","volume":"161","author":"Lehrke","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.047_bib241","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12967-021-03220-7","article-title":"Role of Chemerin\/ChemR23 axis as an emerging therapeutic perspective on obesity-related vascular dysfunction","volume":"20","author":"Xie","year":"2022","journal-title":"J Transl Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib242","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1172\/JCI32239","article-title":"Angiogenesis modulates adipogenesis and obesity","volume":"117","author":"Cao","year":"2007","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib243","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1186\/s12916-022-02672-y","article-title":"Obese visceral fat tissue inflammation: from protective to detrimental?.","volume":"20","author":"Kolb","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib244","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrendo.2017.90","article-title":"Adapting to obesity with adipose tissue inflammation","volume":"13","author":"Reilly","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.047_bib245","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00424-023-02824-w","article-title":"Regulation of endothelial function by cigarette smoke and next-generation tobacco and nicotine products","volume":"475","author":"Klein","year":"2023","journal-title":"Pflugers Arch"},{"key":"10.1016\/j.apsb.2026.06.047_bib246","first-page":"4136811","article-title":"Electronic cigarette and atherosclerosis: a comprehensive literature review of latest evidence","volume":"2022","author":"Damay","year":"2022","journal-title":"Int J Vasc Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib247","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1093\/cvr\/cvac140","article-title":"Nicotine exacerbates endothelial dysfunction and drives atherosclerosis via extracellular vesicle-miRNA","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib248","doi-asserted-by":"crossref","first-page":"50","DOI":"10.4070\/kcj.2024.0171","article-title":"The effects of nicotine on re-endothelialization, inflammation, and neoatherosclerosis after drug-eluting stent implantation in a porcine model","volume":"55","author":"Oh","year":"2025","journal-title":"Korean Circ J"},{"key":"10.1016\/j.apsb.2026.06.047_bib249","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1093\/ntr\/ntae274","article-title":"The role of sex in the effects of smoking and nicotine on cardiovascular function, atherosclerosis, and inflammation","volume":"27","author":"Centner","year":"2025","journal-title":"Nicotine Tob Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib250","doi-asserted-by":"crossref","first-page":"276","DOI":"10.2174\/157016107782023406","article-title":"Structural and functional alteration of blood vessels caused by cigarette smoking: an overview of molecular mechanisms","volume":"5","author":"Rahman","year":"2007","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib251","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.967047","article-title":"Cigarette smoking and air pollution exposure and their effects on cardiovascular diseases","volume":"11","author":"Mallah","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.apsb.2026.06.047_bib252","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1038\/s41440-023-01455-z","article-title":"Smoking cessation and vascular endothelial function","volume":"46","author":"Higashi","year":"2023","journal-title":"Hypertens Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib253","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/jcm9051328","article-title":"ROCK (RhoA\/Rho Kinase) in cardiovascular-renal pathophysiology: a review of new advancements","volume":"9","author":"Seccia","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib254","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/10937404.2023.2208886","article-title":"Animal models and mechanisms of tobacco smoke-induced chronic obstructive pulmonary disease (COPD)","volume":"26","author":"Upadhyay","year":"2023","journal-title":"J Toxicol Environ Health B Crit Rev"},{"key":"10.1016\/j.apsb.2026.06.047_bib255","doi-asserted-by":"crossref","DOI":"10.1016\/j.numecd.2024.08.003","article-title":"Associations of smoking status with carotid atherosclerosis: mediated role of blood indexes and blood pressure","volume":"35","author":"Li","year":"2025","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.apsb.2026.06.047_bib256","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.998380","article-title":"Detrimental effects of physical inactivity on peripheral and brain vasculature in humans: insights into mechanisms, long-term health consequences and protective strategies","volume":"13","author":"Daniele","year":"2022","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib257","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1089\/ars.2009.2487","article-title":"Molecular mechanisms responsible for the atheroprotective effects of laminar shear stress","volume":"11","author":"Pan","year":"2009","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2026.06.047_bib258","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1084\/jem.20180483","article-title":"Piezo1 and Gq\/G11 promote endothelial inflammation depending on flow pattern and integrin activation","volume":"215","author":"Albarran Juarez","year":"2018","journal-title":"J Exp Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib259","doi-asserted-by":"crossref","first-page":"37622","DOI":"10.18632\/oncotarget.9376","article-title":"A novel TRPV4-specific agonist inhibits monocyte adhesion and atherosclerosis","volume":"7","author":"Xu","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.apsb.2026.06.047_bib260","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2022.108152","article-title":"Endothelial shear stress signal transduction and atherogenesis: from mechanisms to therapeutics","volume":"235","author":"He","year":"2022","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.apsb.2026.06.047_bib261","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1161\/CIRCRESAHA.120.316857","article-title":"Coupling of integrin \u03b15 to annexin A2 by flow drives endothelial activation","volume":"127","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib262","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1161\/ATVBAHA.118.312301","article-title":"Atheroprotective flow upregulates ITPR3 (inositol 1,4,5-trisphosphate receptor 3) in vascular endothelium via KLF4 (kruppel-like factor 4)-mediated histone modifications","volume":"39","author":"He","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib263","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1161\/CIRCRESAHA.121.319540","article-title":"Deletion of BACH1 attenuates atherosclerosis by reducing endothelial inflammation","volume":"130","author":"Jia","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib264","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/cvr\/cvaf024","article-title":"Endothelial c-REL orchestrates atherosclerosis at regions of disturbed flow through crosstalk with TXNIP\u2013p38 and non-canonical NF-\u03baB pathways","volume":"121","author":"Tardajos Ayllon","year":"2025","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib265","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/eurheartj\/ehac704","article-title":"Vinculin phosphorylation modulates endothelial cell permeability: a new target for cardiovascular disease?.","volume":"44","author":"Bonacina","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib266","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCRESAHA.122.321322","article-title":"MST1 suppresses disturbed flow induced atherosclerosis","volume":"131","author":"Quan","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib267","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/s44161-024-00522-z","article-title":"Endothelial \u03b3-protocadherins inhibit KLF2 and KLF4 to promote atherosclerosis","volume":"3","author":"Joshi","year":"2024","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib268","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/s44161-024-00593-y","article-title":"Phosphorylation of endothelial histone H3.3 serine 31 by PKN1 links flow-induced signaling to proatherogenic gene expression","volume":"4","author":"Jin","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib269","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCRESAHA.125.327048","article-title":"SWAP70 promotes atherosclerosis via endothelial CAV1 nuclear translocation","volume":"138","author":"Gao","year":"2026","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib270","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.1242\/jcs.02541","article-title":"Role of PECAM-1 in the shear-stress-induced activation of Akt and the endothelial nitric oxide synthase (eNOS) in endothelial cells","volume":"118","author":"Fleming","year":"2005","journal-title":"J Cell Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib271","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1093\/cvr\/cvad076","article-title":"Endothelial mechanobiology in atherosclerosis","volume":"119","author":"Wang","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib272","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s44161-024-00591-0","article-title":"Endothelial IGFBP6 suppresses vascular inflammation and atherosclerosis","volume":"4","author":"Su","year":"2025","journal-title":"Nat Cardiovasc Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib273","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1161\/CIRCRESAHA.122.321187","article-title":"Endothelial UCP2 is a mechanosensitive suppressor of atherosclerosis","volume":"131","author":"Luo","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib274","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacadv.2024.101107","article-title":"COVID-19 in the initiation and progression of atherosclerosis: pathophysiology during and beyond the acute phase","volume":"3","author":"Chidambaram","year":"2024","journal-title":"JACC Adv"},{"key":"10.1016\/j.apsb.2026.06.047_bib275","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.apsb.2026.06.047_bib276","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1007\/s10067-022-06497-1","article-title":"SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis","volume":"42","author":"Plazak","year":"2023","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.apsb.2026.06.047_bib277","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140711","article-title":"The complement system in COVID-19: friend and foe?.","volume":"5","author":"Java","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.apsb.2026.06.047_bib278","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nm810","article-title":"Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E","volume":"9","author":"Huo","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib279","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.3390\/ijms24032380","article-title":"Alterations in circulating miRNA levels after infection with SARS-CoV-2 could contribute to the development of cardiovascular diseases: what we know So far","volume":"24","author":"Pieri","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib280","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0129425","article-title":"HIV-1 Tat protein induces production of proinflammatory cytokines by human dendritic cells and monocytes\/macrophages through engagement of TLR4\u2013MD2\u2013CD14 complex and activation of NF-\u03baB pathway","volume":"10","author":"Ben Haij","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.06.047_bib281","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/ATVBAHA.122.318232","article-title":"Cardiovascular disease and thrombosis in HIV infection","volume":"43","author":"Perkins","year":"2023","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib282","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.3390\/ijms25042367","article-title":"HIV Infection drives foam cell formation via NLRP3 inflammasome activation","volume":"25","author":"Caocci","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib283","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107812","article-title":"HIV infection, antiretroviral therapy and vascular dysfunction: effects, mechanisms and treatments","volume":"217","author":"Wei","year":"2025","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib284","series-title":"StatPearls [Internet]","article-title":"HIV-Associated lipodystrophy","author":"Guzman","year":"2022"},{"key":"10.1016\/j.apsb.2026.06.047_bib285","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.leukres.2017.05.008","article-title":"Risk factors and mechanisms contributing to TKI-induced vascular events in patients with CML","volume":"59","author":"Valent","year":"2017","journal-title":"Leuk Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib286","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12883-024-04006-2","article-title":"Cerebrovascular stenosis related to tyrosine kinase inhibitor for chronic myeloid leukemia: two illustrative cases","volume":"25","author":"Sasaki","year":"2025","journal-title":"BMC Neurol"},{"key":"10.1016\/j.apsb.2026.06.047_bib287","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1039\/D4AN01154F","article-title":"Assessing endothelial cytotoxicity induced by tyrosine kinase inhibitors: insights from Raman and fluorescence imaging","volume":"150","author":"Orleanska","year":"2025","journal-title":"The Analyst"},{"key":"10.1016\/j.apsb.2026.06.047_bib288","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1093\/eurheartj\/ehaf196","article-title":"Residual cholesterol and inflammatory risk in statin-treated patients undergoing percutaneous coronary intervention","volume":"46","author":"Bay","year":"2025","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib289","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117031","article-title":"PCSK9 inhibition mitigates vulnerable plaque formation induced by hyperhomocysteinemia through regulating lipid metabolism and inflammation","volume":"239","author":"Jin","year":"2025","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib290","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s12872-025-04892-5","article-title":"Modulation of atherogenesis biomarkers by PCSK9 inhibitors in Lp(a)-stimulated human coronary artery endothelial cells","volume":"25","author":"Zulkapli","year":"2025","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.apsb.2026.06.047_bib291","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.apsb.2022.06.011","article-title":"Development of the novel ACLY inhibitor 326E as a promising treatment for hypercholesterolemia","volume":"13","author":"Xie","year":"2023","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.047_bib292","doi-asserted-by":"crossref","first-page":"4325","DOI":"10.7150\/thno.105782","article-title":"A natural small molecule isoginkgetin alleviates hypercholesterolemia and atherosclerosis by targeting ACLY","volume":"15","author":"Zhang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.06.047_bib293","article-title":"Combination of an ACLY inhibitor with a GLP-1R agonist exerts additive benefits on nonalcoholic steatohepatitis and hepatic fibrosis in mice","volume":"4","author":"Desjardins","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib294","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1074\/jbc.RA119.011857","article-title":"A highly selective inhibitor of interleukin-1 receptor-associated kinases 1\/4 (IRAK-1\/4) delineates the distinct signaling roles of IRAK-1\/4 and the TAK1 kinase","volume":"295","author":"Scarneo","year":"2020","journal-title":"J Biol Chem"},{"key":"10.1016\/j.apsb.2026.06.047_bib295","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10753-019-01098-8","article-title":"Target of MCC950 in inhibition of NLRP3 inflammasome activation: a literature review","volume":"43","author":"Wu","year":"2020","journal-title":"Inflammation"},{"key":"10.1016\/j.apsb.2026.06.047_bib296","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-98437-3","article-title":"The selective NLRP3 inhibitor MCC950 hinders atherosclerosis development by attenuating inflammation and pyroptosis in macrophages","volume":"11","author":"Zeng","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib297","article-title":"JT002, a small molecule inhibitor of the NLRP3 inflammasome for the treatment of autoinflammatory disorders","volume":"13","author":"Ambrus-Aikelin","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib298","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1021\/acsmedchemlett.1c00597","article-title":"New highly potent NLRP3 inhibitors: furanochalcone velutone F analogues","volume":"13","author":"Zhang","year":"2022","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.06.047_bib299","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s12872-020-01391-7","article-title":"Inhibition of JAK2\/STAT3\/SOCS3 signaling attenuates atherosclerosis in rabbit","volume":"20","author":"Yang","year":"2020","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.apsb.2026.06.047_bib300","doi-asserted-by":"crossref","first-page":"e326508","DOI":"10.1161\/CIRCRESAHA.125.326508","article-title":"Neratinib, a clinical drug against breast cancer, protects against vascular inflammation and atherosclerosis","volume":"138","author":"Zhang","year":"2026","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib301","first-page":"3085","article-title":"Baicalein protects against endothelial cell injury by inhibiting the TLR4\/NF-\u03baB signaling pathway","volume":"17","author":"Wan","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib302","first-page":"1381","article-title":"Functional mechanism of baicalein in alleviating severe acute pancreatitis-acute lung injury by blocking the TLR4\/MyD88\/TRIF signaling pathway","volume":"39","author":"Yang","year":"2024","journal-title":"Histol Histopathol"},{"key":"10.1016\/j.apsb.2026.06.047_bib303","article-title":"Inhibition of intimal hyperplasia in murine aortic allografts by administration of a small-molecule TLR4 inhibitor TAK-242","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib304","article-title":"The cGAS\u2013STING pathway in atherosclerosis","volume":"12","author":"Wang","year":"2025","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib305","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.apsb.2021.05.011","article-title":"The cGAS\u2013STING signaling in cardiovascular and metabolic diseases: future novel target option for pharmacotherapy","volume":"12","author":"Oduro","year":"2022","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.047_bib306","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1038\/s41467-017-00833-9","article-title":"Small molecule inhibition of cGAS reduces interferon expression in primary macrophages from autoimmune mice","volume":"8","author":"Vincent","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib307","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.14336\/AD.2022.0316","article-title":"Role of the cGAS\u2013STING pathway in aging-related endothelial dysfunction","volume":"13","author":"Yu","year":"2022","journal-title":"Aging Dis"},{"key":"10.1016\/j.apsb.2026.06.047_bib308","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184843","article-title":"Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay","volume":"12","author":"Hall","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2026.06.047_bib309","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1093\/eurheartj\/ehab249","article-title":"STING, a cytosolic DNA sensor, plays a critical role in atherogenesis: a link between innate immunity and chronic inflammation caused by lifestyle-related diseases","volume":"42","author":"Pham","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib310","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41586-018-0287-8","article-title":"Targeting STING with covalent small-molecule inhibitors","volume":"559","author":"Haag","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib311","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/s41577-021-00524-z","article-title":"The cGAS\u2013STING pathway as a therapeutic target in inflammatory diseases","volume":"21","author":"Decout","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib312","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.1021\/acs.jnatprod.0c00478","article-title":"Flavonoids with inhibitory effects on NLRP3 inflammasome activation from Millettia velutina","volume":"83","author":"Ma","year":"2020","journal-title":"J Nat Prod"},{"key":"10.1016\/j.apsb.2026.06.047_bib313","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1021\/acsmedchemlett.8b00466","article-title":"Discovery of a novel cGAMP competitive ligand of the inactive form of STING","volume":"10","author":"Siu","year":"2019","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.apsb.2026.06.047_bib314","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2018.11.097","article-title":"The cyclopeptide astin C specifically inhibits the innate immune CDN sensor STING","volume":"25","author":"Li","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib315","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/bph.16007","article-title":"Curaxin CBL0137 inhibits endothelial inflammation and atherogenesis via suppression of the Src-YAP signalling axis","volume":"180","author":"Ding","year":"2023","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib316","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/bph.15378","article-title":"Harmine alleviates atherogenesis by inhibiting disturbed flow-mediated endothelial activation via protein tyrosine phosphatase PTPN14 and YAP","volume":"178","author":"Yang","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib317","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adu3919","article-title":"Lysosomal zinc nanomodulation blocks macrophage pyroptosis for counteracting atherosclerosis progression","volume":"11","author":"Hu","year":"2025","journal-title":"Sci Adv"},{"key":"10.1016\/j.apsb.2026.06.047_bib318","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.107162","article-title":"Inhibition of NETosis via PAD4 alleviated inflammation in giant cell myocarditis","volume":"26","author":"Hu","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.apsb.2026.06.047_bib319","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2024.117473","article-title":"Low shear stress exacerbates atherosclerosis by inducing the generation of neutrophil extracellular traps via Piezo1-mediated mechanosensation","volume":"391","author":"Zhu","year":"2024","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.06.047_bib320","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/BJ20090309","article-title":"Inhibition of myeloperoxidase-mediated hypochlorous acid production by nitroxides","volume":"421","author":"Rees","year":"2009","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2026.06.047_bib321","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3390\/antiox12020478","article-title":"Antioxidant strategies to modulate NETosis and the release of neutrophil extracellular traps during chronic inflammation","volume":"12","author":"Hallberg","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/j.apsb.2026.06.047_bib322","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.3390\/ijms23073592","article-title":"Specialized pro-resolving lipid mediators: new therapeutic approaches for vascular remodeling","volume":"23","author":"Diaz Del Campo","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib323","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fimmu.2011.00057","article-title":"Modulation of macrophage efferocytosis in inflammation","volume":"2","author":"Korns","year":"2011","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib324","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2025.115173","article-title":"RvE1\/ChemR23 facilitates hematoma clearance and promotes M2 polarization of macrophages\/microglia in intracerebral hemorrhage","volume":"386","author":"Fang","year":"2025","journal-title":"Exp Neurol"},{"key":"10.1016\/j.apsb.2026.06.047_bib325","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.fob.2012.10.001","article-title":"Resolvin E1 maintains macrophage function under cigarette smoke-induced oxidative stress","volume":"2","author":"Takamiya","year":"2012","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.apsb.2026.06.047_bib326","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/prd.12034","article-title":"Natural resolution of inflammation","volume":"63","author":"Freire","year":"2000","journal-title":"Periodontol"},{"key":"10.1016\/j.apsb.2026.06.047_bib327","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.3390\/biomedicines10112829","article-title":"Critical role of inflammation and specialized pro-resolving mediators in the pathogenesis of atherosclerosis","volume":"10","author":"Rangarajan","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.06.047_bib328","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11626-024-01008-9","article-title":"Resolvin D1 suppresses inflammation in human fibroblast-like synoviocytes via the p-38, NF-\u03baB, and AKT signaling pathways","volume":"61","author":"Yanoshita","year":"2025","journal-title":"In Vitro Cell Dev Biol Anim"},{"key":"10.1016\/j.apsb.2026.06.047_bib329","first-page":"566","article-title":"Resolvin D1 (Rvd1) attenuates in vitro LPS-stimulated inflammation through downregulation of miR-155, miR-146, miR-148 and krupple like factor 5","volume":"12","author":"Amin","year":"2024","journal-title":"Rep Biochem Mol Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib330","article-title":"Maresin: macrophage mediator for resolving inflammation and bridging tissue regeneration-a system-based preclinical systematic review","volume":"24","author":"Liu","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib331","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1172\/JCI129448","article-title":"Maresin 1 activates LGR6 receptor promoting phagocyte immunoresolvent functions","volume":"129","author":"Chiang","year":"2019","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib332","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1172\/JCI97943","article-title":"Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators","volume":"128","author":"Serhan","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib333","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1476-5381.2009.00290.x","article-title":"Resolvins and protectins: mediating solutions to inflammation","volume":"158","author":"Kohli","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib334","doi-asserted-by":"crossref","first-page":"10680","DOI":"10.1096\/fj.201900070R","article-title":"Protective effects of GPR37 via regulation of inflammation and multiple cell death pathways after ischemic stroke in mice","volume":"33","author":"McCrary","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.047_bib335","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1172\/JCI99888","article-title":"GPR37 regulates macrophage phagocytosis and resolution of inflammatory pain","volume":"128","author":"Bang","year":"2018","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib336","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.033881","article-title":"Disulfiram reduces atherosclerosis and enhances efferocytosis, autophagy, and atheroprotective gut microbiota in hyperlipidemic mice","volume":"13","author":"Traughber","year":"2024","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.apsb.2026.06.047_bib337","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1161\/CIRCULATIONAHA.125.075352","article-title":"IRF5 siRNA Nanoimmunotherapy: restoring macrophage efferocytosis in atherosclerosis","volume":"152","author":"He","year":"2025","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib338","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/FJC.0000000000000775","article-title":"Ginsenoside Rb1 alleviates oxidative low-density lipoprotein-induced vascular endothelium senescence via the SIRT1\/Beclin-1\/autophagy axis","volume":"75","author":"Shi","year":"2020","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib339","doi-asserted-by":"crossref","first-page":"464","DOI":"10.3389\/fphar.2018.00464","article-title":"Ginsenoside Rg3 mitigates atherosclerosis progression in diabetic ApoE\u2013\/\u2013 mice by skewing macrophages to the M2 phenotype","volume":"9","author":"Guo","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib340","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109729","article-title":"Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE\u2013\/\u2013 mice by activating PI3K\/AKT signaling and suppressing TRL4\/NF-\u03baB signaling","volume":"123","author":"Wang","year":"2020","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.06.047_bib341","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1007\/s11010-020-04035-8","article-title":"Astragaloside IV alleviates atherosclerosis through targeting circ_0000231\/miR-135a-5p\/CLIC4 axis in AS cell model in vitro","volume":"476","author":"Shao","year":"2021","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.apsb.2026.06.047_bib342","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/s41522-024-00585-7","article-title":"EphA2 blockage ALW-II-41-27 alleviates atherosclerosis by remodeling gut microbiota to regulate bile acid metabolism","volume":"10","author":"Lu","year":"2024","journal-title":"NPJ Biofilms Microbiomes"},{"key":"10.1016\/j.apsb.2026.06.047_bib343","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.atherosclerosis.2023.03.011","article-title":"Empagliflozin ameliorates atherosclerosis via regulating the intestinal flora","volume":"371","author":"Hao","year":"2023","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.06.047_bib344","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.cmet.2011.11.006","article-title":"TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading","volume":"14","author":"Pols","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2026.06.047_bib345","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1186\/s12934-021-01720-1","article-title":"The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors","volume":"20","author":"Lin","year":"2021","journal-title":"Microb Cell Fact"},{"key":"10.1016\/j.apsb.2026.06.047_bib346","doi-asserted-by":"crossref","first-page":"561","DOI":"10.3390\/md18110561","article-title":"New monoterpenoids and polyketides from the deep-sea sediment-derived fungus Aspergillus sydowii MCCC 3A00324","volume":"18","author":"Niu","year":"2020","journal-title":"Mar Drugs"},{"key":"10.1016\/j.apsb.2026.06.047_bib347","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113307","article-title":"Meroterpenoids from the fungus Penicillium sclerotiorum GZU-XW03-2 and their anti-inflammatory activity","volume":"202","author":"Zhao","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2026.06.047_bib348","doi-asserted-by":"crossref","DOI":"10.1016\/j.phytochem.2022.113229","article-title":"Bioactive pulvinones from a marine algicolous fungus Aspergillus terreus NTU243","volume":"200","author":"Hsiao","year":"2022","journal-title":"Phytochemistry"},{"key":"10.1016\/j.apsb.2026.06.047_bib349","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.102973","article-title":"Identification of anti-inflammatory polyketides from the coral-derived Fungus Penicillium sclerotiorin: in vitro approaches and molecular-modeling","volume":"88","author":"Liu","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.apsb.2026.06.047_bib350","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2400675121","article-title":"The IRG1\u2013itaconate axis protects from cholesterol-induced inflammation and atherosclerosis","volume":"121","author":"Cyr","year":"2024","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.apsb.2026.06.047_bib351","doi-asserted-by":"crossref","DOI":"10.1172\/JCI173034","article-title":"Itaconate suppresses atherosclerosis by activating a Nrf2-dependent antiinflammatory response in macrophages in mice","volume":"134","author":"Song","year":"2023","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib352","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118205","article-title":"Ginsenoside Rg1 alleviates chronic inflammation-induced neuronal ferroptosis and cognitive impairments via regulation of AIM2\u2013Nrf2 signaling pathway","volume":"330","author":"Kong","year":"2024","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib353","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.jgr.2024.01.006","article-title":"Ginsenoside Rg5, a potent agonist of Nrf2, inhibits HSV-1 infection-induced neuroinflammation by inhibiting oxidative stress and NF-\u03baB activation","volume":"48","author":"Kim","year":"2024","journal-title":"J Ginseng Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib354","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115038","article-title":"Caffeoylquinic acids isolated from Lonicera japonica Thunb. as TAK1 inhibitors protect against LPS plus IFN-\u03b3-stimulated inflammation by interacting with KEAP1-regulated NRF2 activation","volume":"165","author":"Ge","year":"2023","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.apsb.2026.06.047_bib355","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/s12944-023-01969-y","article-title":"Puerarin ameliorates metabolic dysfunction-associated fatty liver disease by inhibiting ferroptosis and inflammation","volume":"22","author":"Yang","year":"2023","journal-title":"Lipids Health Dis"},{"key":"10.1016\/j.apsb.2026.06.047_bib356","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1360177","article-title":"Celastrol alleviates diabetic vascular injury via Keap1\/Nrf2-mediated anti-inflammation","volume":"15","author":"An","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib357","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1526623","article-title":"Paeonol ameliorates ferroptosis and inflammation in chondrocytes through AMPK\/Nrf2\/GPX4 pathway","volume":"16","author":"Gong","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib358","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s42255-022-00577-x","article-title":"Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism","volume":"4","author":"Chen","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/j.apsb.2026.06.047_bib359","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.113222","article-title":"GLP-1 analogue liraglutide attenuates CIH-induced cognitive deficits by inhibiting oxidative stress, neuroinflammation, and apoptosis via the Nrf2\/HO-1 and MAPK\/NF-\u03baB signaling pathways","volume":"142","author":"Lv","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib360","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232113477","article-title":"Trichostatin D as a novel KLF2 activator attenuates TNF\u03b1-induced endothelial inflammation","volume":"23","author":"Lei","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib361","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/biomedicines10020254","article-title":"The role of KLF2 in the regulation of atherosclerosis development and potential use of KLF2-targeted therapy","volume":"10","author":"Dabravolski","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.06.047_bib362","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1016\/j.apsb.2025.05.015","article-title":"IMM-H007 promotes hepatic cholesterol and triglyceride metabolism by activating AMPK\u03b1 to attenuate hypercholesterolemia","volume":"15","author":"Li","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2026.06.047_bib363","article-title":"LDL-binding IL-10 reduces vascular inflammation in atherosclerotic mice","author":"Volpatti","year":"2024","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/j.apsb.2026.06.047_bib364","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10753-025-02446-7","article-title":"Narciclasine alleviates endothelial inflammation and atherosclerosis initiation by inhibiting histone lactylation-mediated NF-\u03baB activation","volume":"49","author":"Wang","year":"2026","journal-title":"Inflammation"},{"key":"10.1016\/j.apsb.2026.06.047_bib365","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1133354","article-title":"Regulation of innate immune signaling by IRAK proteins","volume":"14","author":"Pereira","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib366","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1089\/ars.2010.3522","article-title":"Vascular cell adhesion molecule-1 expression and signaling during disease: regulation by reactive oxygen species and antioxidants","volume":"15","author":"Cook Mills","year":"2011","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.apsb.2026.06.047_bib367","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.regpep.2012.01.004","article-title":"Pathogenic involvement of heregulin-\u03b21 in anti-atherogenesis","volume":"175","author":"Watanabe","year":"2012","journal-title":"Regul Pept"},{"key":"10.1016\/j.apsb.2026.06.047_bib368","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.106043","article-title":"Pharmacological inhibition of IRAK1 and IRAK4 prevents endothelial inflammation and atherosclerosis in ApoE\u2013\/\u2013 mice","volume":"175","author":"Wu","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib369","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3390\/biom14010029","article-title":"High phosphate-induced JAK\u2013STAT signalling sustains vascular smooth muscle cell inflammation and limits calcification","volume":"14","author":"Macri","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.apsb.2026.06.047_bib370","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/eurheartj\/ehae205","article-title":"Myocardial reperfusion injury exacerbation due to ALDH2 deficiency is mediated by neutrophil extracellular traps and prevented by leukotriene C4 inhibition","volume":"45","author":"Yang","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib371","article-title":"Molecular mechanisms and therapeutic target of NETosis in diseases","volume":"3","author":"Huang","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.apsb.2026.06.047_bib372","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.smim.2018.09.002","article-title":"Pro-resolving lipid mediators: agents of anti-ageing?.","volume":"40","author":"Doyle","year":"2018","journal-title":"Semin Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib373","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.3390\/ijms23063133","article-title":"Specialized proresolving lipid mediators: a potential therapeutic target for atherosclerosis","volume":"23","author":"Salazar","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib374","article-title":"Inflammation resolution-based treatment of atherosclerosis using biomimetic nanocarriers loaded with specialized pro-resolving lipid mediators","volume":"32","author":"Anghelache","year":"2025","journal-title":"Mater Today Bio"},{"key":"10.1016\/j.apsb.2026.06.047_bib375","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2025.120594","article-title":"C-reactive protein exacerbates high-fat diet-induced atherosclerosis via a liver-to-vessel axis that determines therapeutic efficacy of atorvastatin","volume":"412","author":"Fu","year":"2026","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.apsb.2026.06.047_bib376","doi-asserted-by":"crossref","DOI":"10.1016\/j.immuni.2023.06.026","article-title":"Cell-autonomous regulation of complement C3 by factor H limits macrophage efferocytosis and exacerbates atherosclerosis","volume":"56","author":"Kiss","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.apsb.2026.06.047_bib377","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/ng912","article-title":"Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H","volume":"31","author":"Pickering","year":"2002","journal-title":"Nat Genet"},{"key":"10.1016\/j.apsb.2026.06.047_bib378","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.7150\/thno.93036","article-title":"Disturbed flow impairs MerTK-mediated efferocytosis in aortic endothelial cells during atherosclerosis","volume":"14","author":"Wu","year":"2024","journal-title":"Theranostics"},{"key":"10.1016\/j.apsb.2026.06.047_bib379","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nature08296","article-title":"Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance","volume":"461","author":"Elliott","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib380","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis","volume":"467","author":"Chekeni","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib381","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41573-022-00470-y","article-title":"Drugging the efferocytosis process: concepts and opportunities","volume":"21","author":"Mehrotra","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.apsb.2026.06.047_bib382","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202400639R","article-title":"Restoration of miR-299-3p promotes efferocytosis and ameliorates atherosclerosis via repressing CD47 in mice","volume":"38","author":"Zhu","year":"2024","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.047_bib383","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1016\/j.jacc.2023.02.007","article-title":"Combination moderate-intensity statin and ezetimibe therapy for elderly patients with atherosclerosis","volume":"81","author":"Lee","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib384","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1093\/eurheartj\/ehac782","article-title":"RACING to judgement: weighing the value of pre-specified subgroup analyses","volume":"44","author":"Stone","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib385","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1093\/eurheartj\/ehac615","article-title":"Effect of inclisiran on lipids in primary prevention: the ORION-11 trial","volume":"43","author":"Ray","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib386","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ahj.2021.04.006","volume":"238","author":"Zanchin","year":"2021","journal-title":"Am Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib387","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.3390\/biomedicines13061460","article-title":"Reshaping dyslipidaemia treatment with bempedoic acid\u2014a narrative review","volume":"13","author":"Strikic","year":"2025","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.06.047_bib388","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011662","article-title":"Efficacy and safety of bempedoic acid in patients with hypercholesterolemia and statin intolerance","volume":"8","author":"Laufs","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.apsb.2026.06.047_bib389","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1001\/jamacardio.2023.5155","article-title":"Impact of bempedoic acid on total cardiovascular events: a prespecified analysis of the CLEAR outcomes randomized clinical trial","volume":"9","author":"Nicholls","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib390","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s11883-022-01054-2","article-title":"Bempedoic acid: for whom and when","volume":"24","author":"Ruscica","year":"2022","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib391","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s10557-021-07147-5","article-title":"Role of bempedoic acid in clinical practice","volume":"35","author":"Ballantyne","year":"2021","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/j.apsb.2026.06.047_bib392","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","article-title":"The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA heart study","volume":"36","author":"Morton","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib393","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014941","article-title":"Interleukin-1 blockade inhibits the acute inflammatory response in patients with ST-segment-elevation myocardial infarction","volume":"9","author":"Abbate","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.apsb.2026.06.047_bib394","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1161\/CIRCULATIONAHA.121.054610","article-title":"Colchicine in patients with acute coronary syndrome: two-year follow-up of the Australian COPS randomized clinical trial","volume":"144","author":"Tong","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib395","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib396","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/acr.23875","article-title":"Comparative risk of cardiovascular events with biologic and synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"72","author":"Singh","year":"2020","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib397","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib398","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s12933-019-0871-8","article-title":"Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial","volume":"18","author":"Leiter","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.apsb.2026.06.047_bib399","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa2501006","article-title":"Oral semaglutide and cardiovascular outcomes in high-risk type 2 diabetes","volume":"392","author":"McGuire","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib400","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib401","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.apsb.2026.06.047_bib402","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/CIRCULATIONAHA.121.057934","article-title":"Efpeglenatide and clinical outcomes with and without concomitant sodium-glucose cotransporter-2 inhibition use in type 2 diabetes: exploratory analysis of the AMPLITUDE-O trial","volume":"145","author":"Lam","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib403","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-078242","article-title":"Effect of combination treatment with glucagon-like peptide-1 receptor agonists and sodium-glucose cotransporter-2 inhibitors on incidence of cardiovascular and serious renal events: population based cohort study","volume":"385","author":"Simms Williams","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/j.apsb.2026.06.047_bib404","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12933-023-02118-6","article-title":"GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes","volume":"23","author":"Marfella","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.apsb.2026.06.047_bib405","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1161\/CIRCULATIONAHA.119.042007","article-title":"Canagliflozin and cardiovascular and renal outcomes in type 2 diabetes mellitus and chronic kidney disease in primary and secondary cardiovascular prevention groups","volume":"140","author":"Mahaffey","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.apsb.2026.06.047_bib406","article-title":"A decade of progress in type 2 diabetes and cardiovascular disease: advances in SGLT2 inhibitors and GLP-1 receptor agonists\u2014a comprehensive review","volume":"16","author":"Aristiz\u00e1bal Colorado","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.apsb.2026.06.047_bib407","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib408","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1186\/s12902-023-01512-1","article-title":"The effect of sodium-glucose co-transporter-2 (SGLT2) inhibitors on blood interleukin-6 concentration: a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Gohari","year":"2023","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/j.apsb.2026.06.047_bib409","article-title":"Effects of metformin treatment on the risk of acute myocardial infarction","volume":"15","author":"Chang","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib410","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2025.1580645","article-title":"Finerenone in diabetic kidney disease: a new frontier for slowing disease progression","volume":"12","author":"Alhomoud","year":"2025","journal-title":"Front Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib411","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with Finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib412","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib413","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of Finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib414","doi-asserted-by":"crossref","first-page":"3553","DOI":"10.1038\/s41591-025-03951-w","article-title":"Antibody-mediated LOX-1 inhibition in patients with residual inflammation after myocardial infarction: a randomized phase 2 trial","volume":"31","author":"O'Donoghue","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib415","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1038\/s41569-025-01226-y","article-title":"LOX1 blockade does not modify atherosclerosis progression in patients with MI","volume":"22","author":"Fern\u00e1ndez","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib416","first-page":"1662","article-title":"Effect of Argatroban plus dual antiplatelet in branch atherosclerosis disease: a randomized clinical trial","volume":"56","author":"Xu","year":"2025","journal-title":"Stroke"},{"key":"10.1016\/j.apsb.2026.06.047_bib417","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40119-024-00376-3","article-title":"Recent advances in targeted management of inflammation in atherosclerosis: a narrative review","volume":"13","author":"Zubiran","year":"2024","journal-title":"Cardiol Ther"},{"key":"10.1016\/j.apsb.2026.06.047_bib418","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1093\/eurheartj\/ehaa659","article-title":"Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)","volume":"41","author":"Bouabdallaoui","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib419","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s11883-024-01267-7","article-title":"Anti-inflammatory therapies in atherosclerosis\u2014where are we going?.","volume":"27","author":"Punnanithinont","year":"2024","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib420","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41569-025-01124-3","article-title":"Colchicine in acute coronary syndromes: the present and the possible future","volume":"22","author":"Imazio","year":"2025","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib421","doi-asserted-by":"crossref","first-page":"3545","DOI":"10.1093\/eurheartj\/ehx723","article-title":"Canakinumab for residual inflammatory risk","volume":"38","author":"Ridker","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib422","doi-asserted-by":"crossref","first-page":"3415","DOI":"10.1093\/eurheartj\/ehae177","article-title":"2024 ESC guidelines for the management of chronic coronary syndromes","volume":"45","author":"Vrints","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib423","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa2405922","article-title":"Colchicine in acute myocardial infarction","volume":"392","author":"Jolly","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib424","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.trsl.2015.06.017","article-title":"Targeting inflammation in metabolic syndrome","volume":"167","author":"Welty","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib425","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.3390\/ijms26051921","article-title":"PCSK9 enhances cardiac fibrogenesis via the activation of toll-like receptor and NLRP3 inflammasome signaling","volume":"26","author":"Chung","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib426","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/ATVBAHA.123.320391","article-title":"Disruption of PCSK9 suppresses inflammation and attenuates abdominal aortic aneurysm formation","volume":"45","author":"Peng","year":"2025","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.apsb.2026.06.047_bib427","doi-asserted-by":"crossref","first-page":"465","DOI":"10.4103\/idoj.idoj_452_22","article-title":"Which is the ideal JAK inhibitor for alopecia areata\u2014Baricitinib, Tofacitinib, Ritlecitinib or Ifidancitinib\u2014Revisiting the immunomechanisms of the JAK pathway","volume":"14","author":"Sardana","year":"2023","journal-title":"Indian Dermatol Online J"},{"key":"10.1016\/j.apsb.2026.06.047_bib428","article-title":"Immune checkpoint inhibitor therapy and acute coronary syndrome: a review of mechanisms and management","author":"Saganty","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.apsb.2026.06.047_bib429","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2025.107493","article-title":"IL-1\u03b2 inhibition in stabilizing atherosclerotic plaques: the critical role of fibroblast-like cells","volume":"159","author":"Xu","year":"2025","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib430","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1038\/s41418-025-01489-5","article-title":"Macrophage junctional adhesion molecule-like (JAML) protein promotes NLRP3 inflammasome activation in the development of atherosclerosis","volume":"32","author":"Cui","year":"2025","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.apsb.2026.06.047_bib431","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1186\/s12933-024-02368-y","article-title":"Longitudinal assessment of coronary plaque regression related to sodium-glucose cotransporter-2 inhibitor using coronary computed tomography angiography","volume":"23","author":"Zhang","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.apsb.2026.06.047_bib432","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jamacardio.2023.2402","article-title":"Adenosine triphosphate citrate lyase and fatty acid synthesis inhibition: a narrative review","volume":"8","author":"Duarte Lau","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib433","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/9763377","article-title":"Advanced glycation end products induce atherosclerosis via RAGE\/TLR4 signaling mediated-M1 macrophage polarization-dependent vascular smooth muscle cell phenotypic conversion","volume":"2022","author":"Xing","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"10.1016\/j.apsb.2026.06.047_bib434","doi-asserted-by":"crossref","first-page":"G1167","DOI":"10.1152\/ajpgi.90496.2008","article-title":"A novel toll-like receptor 4 antagonist antibody ameliorates inflammation but impairs mucosal healing in murine colitis","volume":"296","author":"Ungaro","year":"2009","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib435","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.3390\/molecules29102233","article-title":"Advances in the chemistry and biology of specialised pro-resolving mediators (SPMs)","volume":"29","author":"Byrne","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2026.06.047_bib436","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41586-024-07469-y","article-title":"A body\u2013brain circuit that regulates body inflammatory responses","volume":"630","author":"Jin","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2026.06.047_bib437","article-title":"Identification of immune cell infiltration and diagnostic biomarkers in unstable atherosclerotic plaques by integrated bioinformatics analysis and machine learning","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib438","article-title":"Immune and inflammatory insights in atherosclerosis: development of a risk prediction model through single-cell and bulk transcriptomic analyses","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib439","doi-asserted-by":"crossref","DOI":"10.1016\/j.vph.2025.107499","article-title":"Single-cell RNA sequencing (scRNA-seq) and its insights into cellular heterogeneity in atherosclerosis","volume":"159","author":"Yu","year":"2025","journal-title":"Vascul Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib440","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110130","article-title":"Analysis of immunogenic cell death in atherosclerosis based on scRNA-seq and bulk RNA-seq data","volume":"119","author":"Tian","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib441","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111639","article-title":"CD8+ T cell metabolic rewiring defined by scRNA-seq identifies a critical role of ASNS expression dynamics in T cell differentiation","volume":"41","author":"Fernandez Garcia","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib442","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12933-024-02195-1","article-title":"Persistent epigenetic signals propel a senescence-associated secretory phenotype and trained innate immunity in CD34+ hematopoietic stem cells from diabetic patients","volume":"23","author":"Vinci","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.apsb.2026.06.047_bib443","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202500802R","article-title":"Trained immunity induced by oxidized low-density lipoprotein is dependent on glutaminolysis","volume":"39","author":"Scarpa","year":"2025","journal-title":"FASEB J"},{"key":"10.1016\/j.apsb.2026.06.047_bib444","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41569-023-00894-y","article-title":"Trained immunity in atherosclerotic cardiovascular disease","volume":"20","author":"Riksen","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib445","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.3390\/jcm11123369","article-title":"Trained immunity as a trigger for atherosclerotic cardiovascular disease-a literature review","volume":"11","author":"Zieleniewska","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.apsb.2026.06.047_bib446","doi-asserted-by":"crossref","DOI":"10.1172\/JCI147719","article-title":"Single-cell RNA sequencing reveals induction of distinct trained-immunity programs in human monocytes","volume":"132","author":"Zhang","year":"2022","journal-title":"J Clin Investig"},{"key":"10.1016\/j.apsb.2026.06.047_bib447","article-title":"Enhanced trained immunity in peripheral monocytes in unstable angina with elevated high-sensitivity C-reactive protein","volume":"10","author":"Zhang","year":"2025","journal-title":"JACC, Basic Transl Sci"},{"key":"10.1016\/j.apsb.2026.06.047_bib448","article-title":"Trained immunity in monocyte\/macrophage: novel mechanism of phytochemicals in the treatment of atherosclerotic cardiovascular disease","volume":"14","author":"Wang","year":"2023","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib449","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12951-023-01899-y","article-title":"Insights into the toxicological effects of nanomaterials on atherosclerosis: mechanisms involved and influence factors","volume":"21","author":"Chen","year":"2023","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2026.06.047_bib450","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2023.107923","article-title":"Pollution from fine particulate matter and atherosclerosis: a narrative review","volume":"175","author":"Macchi","year":"2023","journal-title":"Environ Int"},{"key":"10.1016\/j.apsb.2026.06.047_bib451","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.117755","article-title":"Association between joint exposure to ambient air pollutants and carotid plaque: the mediating role of cardiometabolic risk factors","volume":"290","author":"Li","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/j.apsb.2026.06.047_bib452","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1161\/HYPERTENSIONAHA.122.18732","article-title":"Noise and air pollution as risk factors for hypertension: part I-epidemiology","volume":"80","author":"Hahad","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.apsb.2026.06.047_bib453","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1161\/HYPERTENSIONAHA.123.20617","article-title":"Noise and air pollution as risk factors for hypertension: part II-pathophysiologic insight","volume":"80","author":"Hahad","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/j.apsb.2026.06.047_bib454","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.autrev.2013.06.016","article-title":"The association between silica exposure and development of ANCA-associated vasculitis: systematic review and meta-analysis","volume":"12","author":"Gomez-Puerta","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.apsb.2026.06.047_bib455","article-title":"Environmental factors influencing the risk of ANCA-associated vasculitis","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.apsb.2026.06.047_bib456","doi-asserted-by":"crossref","first-page":"8034","DOI":"10.1038\/s41467-024-52005-1","article-title":"Pro-efferocytic nanotherapies reduce vascular inflammation without inducing anemia in a large animal model of atherosclerosis","volume":"15","author":"Bamezai","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2026.06.047_bib457","doi-asserted-by":"crossref","DOI":"10.34133\/2022\/9845459","article-title":"Platelet membrane-coated nanocarriers targeting plaques to deliver anti-CD47 antibody for atherosclerotic therapy","volume":"2022","author":"Chen","year":"2022","journal-title":"Research"},{"key":"10.1016\/j.apsb.2026.06.047_bib458","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/biomedicines12071504","article-title":"Targeted delivery of nanoparticles to blood vessels for the treatment of atherosclerosis","volume":"12","author":"Zong","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/j.apsb.2026.06.047_bib459","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.952523","article-title":"Recent advancement of bioinspired nanomaterials and their applications: a review","volume":"10","author":"Wu","year":"2022","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.apsb.2026.06.047_bib460","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1186\/s12951-025-03384-0","article-title":"Targeted drug delivery systems for atherosclerosis","volume":"23","author":"Tu","year":"2025","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.apsb.2026.06.047_bib461","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13045-024-01574-1","article-title":"Lipid-based nanosystems: the next generation of cancer immune therapy","volume":"17","author":"Cheng","year":"2024","journal-title":"J Hematol Oncol"},{"key":"10.1016\/j.apsb.2026.06.047_bib462","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00011-024-01968-4","article-title":"A universal gene expression signature-based strategy for the high-throughput discovery of anti-inflammatory drugs","volume":"74","author":"Feng","year":"2025","journal-title":"Inflamm Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib463","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1161\/CIRCRESAHA.123.322737","article-title":"ADAMTS-7 modulates atherosclerotic plaque formation by degradation of TIMP-1","volume":"133","author":"Sharifi","year":"2023","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib464","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1021\/acs.jmedchem.3c02098","article-title":"Discovery of potent, orally bioavailable, tricyclic NLRP3 inhibitors","volume":"67","author":"Velcicky","year":"2024","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2026.06.047_bib465","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1161\/CIRCRESAHA.123.323156","article-title":"Gs\u03b1 regulates macrophage foam cell formation during atherosclerosis","volume":"134","author":"Ma","year":"2024","journal-title":"Circ Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib466","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1052-5157(18)30351-9","article-title":"Nonsteroidal anti-inflammatory drug gastropathy","volume":"6","author":"Laine","year":"1996","journal-title":"Gastrointest Endosc Clin N Am"},{"key":"10.1016\/j.apsb.2026.06.047_bib467","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3121\/cmr.2007.698","article-title":"An evidence-based update on nonsteroidal anti-inflammatory drugs","volume":"5","author":"Ong","year":"2007","journal-title":"Clin Med Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib468","article-title":"Effects of non-steroidal anti-inflammatory drugs (NSAIDs) and gastroprotective NSAIDs on the gastrointestinal tract: a narrative review","volume":"15","author":"Sohail","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.apsb.2026.06.047_bib469","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1093\/eurheartj\/ehae208","article-title":"Low-dose colchicine for atherosclerosis: long-term safety","volume":"45","author":"Nidorf","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.apsb.2026.06.047_bib470","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11883-024-01241-3","article-title":"Targeting inflammatory pathways in atherosclerosis: exploring new opportunities for treatment","volume":"26","author":"d'Aiello","year":"2024","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.apsb.2026.06.047_bib471","doi-asserted-by":"crossref","first-page":"6745","DOI":"10.1039\/D0FO01237H","article-title":"Dietary bioactive ingredients to modulate the gut microbiota-derived metabolite TMAO. New opportunities for functional food development","volume":"11","author":"Simo","year":"2020","journal-title":"Food Funct"},{"key":"10.1016\/j.apsb.2026.06.047_bib472","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2077602","article-title":"Deficiency of PSRC1 accelerates atherosclerosis by increasing TMAO production via manipulating gut microbiota and flavin monooxygenase 3","volume":"14","author":"Luo","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.apsb.2026.06.047_bib473","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106586","article-title":"Gut microbiome and metabolites, the future direction of diagnosis and treatment of atherosclerosis?.","volume":"187","author":"Cao","year":"2023","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib474","first-page":"301","article-title":"Trimethylamine N-oxide (TMAO) in human health","volume":"20","author":"Gatarek","year":"2021","journal-title":"EXCLI J"},{"key":"10.1016\/j.apsb.2026.06.047_bib475","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1079\/PNS2002207","article-title":"Regulation of short-chain fatty acid production","volume":"62","author":"Macfarlane","year":"2003","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.apsb.2026.06.047_bib476","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fphar.2018.00533","article-title":"The anti-inflammatory effects of short chain fatty acids on lipopolysaccharide- or tumor necrosis factor \u03b1-stimulated endothelial cells via activation of GPR41\/43 and inhibition of HDACs","volume":"9","author":"Li","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.apsb.2026.06.047_bib477","doi-asserted-by":"crossref","first-page":"8801","DOI":"10.3390\/molecules27248801","article-title":"Short-chain fatty acids weaken Ox-LDL-induced cell inflammatory injury by inhibiting the NLRP3\/Caspase-1 pathway and affecting cellular metabolism in THP-1 cells","volume":"27","author":"Yi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2026.06.047_bib478","article-title":"Mechanism of bile acid in regulating platelet function and thrombotic diseases","volume":"11","author":"Zhou","year":"2024","journal-title":"Adv Sci (Weinh)"},{"key":"10.1016\/j.apsb.2026.06.047_bib479","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1194\/jlr.M067363","article-title":"Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes","volume":"57","author":"Dijk","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/j.apsb.2026.06.047_bib480","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s13238-012-2036-3","article-title":"MiR-122 in hepatic function and liver diseases","volume":"3","author":"Hu","year":"2012","journal-title":"Protein Cell"},{"key":"10.1016\/j.apsb.2026.06.047_bib481","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1002\/j.2040-4603.2014.tb00592.x","article-title":"Central nervous system regulation of brown adipose tissue","volume":"4","author":"Morrison","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/j.apsb.2026.06.047_bib482","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/s41419-024-07166-8","article-title":"Inflammation in atherosclerosis: pathophysiology and mechanisms","volume":"15","author":"Ajoolabady","year":"2024","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.apsb.2026.06.047_bib483","doi-asserted-by":"crossref","first-page":"430","DOI":"10.3389\/fncel.2014.00430","article-title":"Brain-derived neurotrophic factor: a bridge between inflammation and neuroplasticity","volume":"8","author":"Calabrese","year":"2014","journal-title":"Front Cell Neurosci"},{"key":"10.1016\/j.apsb.2026.06.047_bib484","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202400919","article-title":"In vitro modeling of atherosclerosis using iPSC-derived blood vessel organoids","volume":"14","author":"Kong","year":"2025","journal-title":"Adv Healthc Mater"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383526004041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T19:58:32Z","timestamp":1786046312000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383526004041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":484,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2211383526004041"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.047","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inflammation in atherosclerosis: Drivers, mechanisms and therapies","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2026.06.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences.","name":"copyright","label":"Copyright"}]}}